Matthew H. Kulke
- Oncology top 0.1%
- Epidemiology top 0.1%
- Neurology top 0.05%
- Molecular Biology top 5%
- Pulmonary and Respiratory Medicine top 1%
- Co-authors
- Robert J. MayerCharles S. FuchsDavid P. RyanJames C. YaoJennifer A. ChanJeffrey W. ClarkPeter C. EnzingerJeffrey A. Meyerhardt
- Topics
- Neuroendocrine Tumor Research Advances (183 papers)Lung Cancer Research Studies (136 papers)Neuroblastoma Research and Treatments (131 papers)
- Cited by
- NeurologyOncologyEpidemiology
- Journals
- New England Journal of MedicineProceedings of the National Academy of SciencesNucleic Acids Research
- Partner nations
- United StatesGermanyUnited Kingdom
In The Last Decade
Matthew H. Kulke
250 papers receiving 12.4k citations
Hit Papers
Peers
Comparison fields: 5 of 125
- Oncology 9.3k
- Epidemiology 8.3k
- Neurology 5.9k
- Molecular Biology 1.9k
- Pulmonary and Respiratory Medicine 1.4k
Countries citing papers authored by Matthew H. Kulke
This map shows the geographic impact of Matthew H. Kulke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew H. Kulke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew H. Kulke more than expected).
Fields of papers citing papers by Matthew H. Kulke
This network shows the impact of papers produced by Matthew H. Kulke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew H. Kulke. The network helps show where Matthew H. Kulke may publish in the future.
Co-authorship network of co-authors of Matthew H. Kulke
This figure shows the co-authorship network connecting the top 25 collaborators of Matthew H. Kulke. A scholar is included among the top collaborators of Matthew H. Kulke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthew H. Kulke. Matthew H. Kulke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 18 | |
| 3 | 9 | |
| 4 | Efficacy and Safety of Telotristat Ethyl in Patients With Carcinoid Syndrome Inadequately Controlled by Somatostatin Analogs : Analysis of the Completed TELESTAR Extension Period | 2 |
| 5 | Time to Sustained Improvement in Bowel Movement Frequency With Telotristat Ethyl : Analysis of the Phase 3 TELESTAR Study | 2 |
| 6 | 25 | |
| 7 | 82 | |
| 8 | 110 | |
| 9 | 19 | |
| 10 | Telotristat etiprate shows benefit in treating patients With carcinoid syndrome that is inadequately controlled by somatostatin analog therapy in the phase 3 TELESTAR clinical trial | 1 |
| 11 | Assessing Treatment Benefit of Telotristat Etiprate in Patients with Carcinoid Syndrome : Patient Exit Interviews | 1 |
| 12 | 19 | |
| 13 | Consensus Guidelines for the Management and Treatment of Neuroendocrine Tumorsbreakdown → | 426 |
| 14 | 207 | |
| 15 | 21 | |
| 16 | 45 | |
| 17 | 39 | |
| 18 | Daily Oral Everolimus Activity in Patients With Metastatic Pancreatic Neuroendocrine Tumors After Failure of Cytotoxic Chemotherapy: A Phase II Trialbreakdown → | 487 |
| 19 | 71 | |
| 20 | 68 |
About Matthew H. Kulke
Matthew H. Kulke is a scholar working on Neurology, Oncology and Epidemiology, having authored 253 papers that have together received 12.7k indexed citations. Recurring topics across this work include Neuroendocrine Tumor Research Advances (183 papers), Lung Cancer Research Studies (136 papers) and Neuroblastoma Research and Treatments (131 papers). The work is most often cited by research in Neurology (5.9k citations), Oncology (9.3k citations) and Epidemiology (8.3k citations). Matthew H. Kulke has collaborated with scholars based in United States, Germany and United Kingdom. Frequent co-authors include Robert J. Mayer, Charles S. Fuchs, David P. Ryan, James C. Yao, Jennifer A. Chan, Jeffrey W. Clark, Peter C. Enzinger, Jeffrey A. Meyerhardt, Jonathan Strosberg and Keith Stuart. Their work appears in journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Nucleic Acids Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.